Must See OTC Watchlist: WHSI, TRGO, NRXP, VDRM, AMYZF, AFOM

On Wednesday there were plenty of stocks which had managed to make a strong upward move and it is likely that many of those stocks would come into focus among investors today. However, at the same time, it is also necessary to keep in mind that it may be quite difficult for investors to keep track of all the stocks which may have rallied yesterday. Hence, it is necessary to…

August 4, 2022
Read More >>

NRX Pharmaceuticals Inc (NASDAQ: NRXP) Announces the Beginning of Crisis use Exercise and Addition of Phase 2/3 Inhaled ZYESAMI™ Pilot in Georgia

July 24, 2021

NRX Pharmaceuticals Inc (NASDAQ: NRXP) announced it is starting scientific training of Nation of Georgia (Georgia) ICU doctors in the use of circulatory ZYESAMI™ for crisis use in patients suffering from Acute COVID-19, and gasped ZYESAMI™ for usage in phase 2/3 scientific trials, for patients in sorrow with COVID-19. NRx lengthens its unending Phase 2/3 pilot of gasped ZYESAMI™ to Georgia NRx also announced that the continuing stage 2/3 pilot…

Read More >>

Relief Therapeutics Inc.’s (OTCMKTS: RLFTF) Partner, NRx Pharmaceuticals Inc. (NASDAQ: NRXP), Studying Aviptadil In COVID-19 Treatment

July 14, 2021

Relief Therapeutics Inc. (OTCMKTS: RLFTF) has announced that NRx Pharmaceuticals Inc. (NASDAQ: NRXP), its collaboration partner, and Quantum Leap Healthcare Collaborative have commenced patient treatment with inhaled Aviptadil in phase 2 adaptive platform trial, I-SPY COVID Trial, in enhancing treatment for critically and severely ill SARS-CoV-2 patients.  Relief Therapeutics’ flagship drug candidate evaluated for COVID-19 treatment  The company develops molecules-based clinical-stage programs with historical clinical testing and use for human…

Read More >>